NCT00081874: RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Leukemia, Mantle Cell Lymphoma, Myelofibrosis